888 results on '"Xia, Ningshao"'
Search Results
2. Author Correction: Design of a recombinant asparaginyl ligase for site-specific modification using efficient recognition and nucleophile motifs
3. Combination therapy with oncolytic virus and T cells or mRNA vaccine amplifies antitumor effects
4. Design of a recombinant asparaginyl ligase for site-specific modification using efficient recognition and nucleophile motifs
5. Tpgen: a language model for stable protein design with a specific topology structure
6. Pharmaceutical targeting of OTUB2 sensitizes tumors to cytotoxic T cells via degradation of PD-L1
7. Incidence and Clearance of Anal Human Papillomavirus Infection in 16 164 Individuals, According to Human Immunodeficiency Virus Status, Sex, and Male Sexuality: An International Pooled Analysis of 34 Longitudinal Studies.
8. Age-Specific Prevalence of Anal and Cervical Human Papillomavirus Infection and High-Grade Lesions in 11 177 Women by Human Immunodeficiency Virus Status: A Collaborative Pooled Analysis of 26 Studies.
9. A cryptic site in class 5 epitope of SARS-CoV-2 RBD maintains highly conservation across natural isolates
10. Stepping forward: T-cell redirecting bispecific antibodies in cancer therapy
11. Correction: The potential of swine pseudorabies virus attenuated vaccine for oncolytic therapy against malignant tumors
12. Evolving spike mutations in SARS-CoV-2 Omicron variants facilitate evasion from breakthrough infection-acquired antibodies
13. The potential of swine pseudorabies virus attenuated vaccine for oncolytic therapy against malignant tumors
14. The epidemiology of varicella and effectiveness of varicella vaccine in Ganyu, China: a long-term community surveillance study
15. Nanoparticle-based multivalent human antibodies offer potent and broad neutralization against Omicron sublineages
16. Intranasal influenza-vectored COVID-19 vaccine restrains the SARS-CoV-2 inflammatory response in hamsters
17. An Automated TW3-RUS Bone Age Assessment Method with Ordinal Regression-Based Determination of Skeletal Maturity
18. A non-viral DNA delivery system consisting of multifunctional chimeric peptide fused with zinc-finger protein
19. Construction and characterization of an infectious cDNA clone of human rhinovirus A89
20. Cross-neutralizing antibodies bind a SARS-CoV-2 cryptic site and resist circulating variants.
21. Progress in immunotherapy
22. Truncated glycoprotein E of varicella-zoster virus is an ideal immunogen for Escherichia coli-based vaccine design
23. Current progress in the development of prophylactic and therapeutic vaccines
24. Non-overlapping epitopes on the gHgL-gp42 complex for the rational design of a triple-antibody cocktail against EBV infection
25. Cryo-EM structures reveal the molecular basis of receptor-initiated coxsackievirus uncoating
26. Near-atomic cryo-electron microscopy structures of varicella-zoster virus capsids
27. Infection, pathology and interferon treatment of the SARS-CoV-2 Omicron BA.1 variant in juvenile, adult and aged Syrian hamsters
28. Identification of Antibodies with Non-overlapping Neutralization Sites that Target Coxsackievirus A16
29. A new mechanism of antibody diversity: formation of the natural antibodies containing LAIR1 and LILRB1 extracellular domains
30. A Chymotrypsin-Dependent Live-Attenuated Influenza Vaccine Provides Protective Immunity against Homologous and Heterologous Viruses
31. Immune escape by SARS-CoV-2 Omicron variant and structural basis of its effective neutralization by a broad neutralizing human antibody VacW-209
32. Nasal irrigation efficiently attenuates SARS-CoV-2 Omicron infection, transmission and lung injury in the Syrian hamster model
33. Atomic structures of enterovirus D68 in complex with two monoclonal antibodies define distinct mechanisms of viral neutralization
34. Bivalent rotavirus VP4∗ stimulates protective antibodies against common genotypes of human rotaviruses
35. Endodomain truncation of the HIV-1 envelope protein improves the packaging efficiency of pseudoviruses
36. An encodable multiplex microsphere-phase amplification sensing platform detects SARS-CoV-2 mutations
37. PIKfyve inhibitors against SARS-CoV-2 and its variants including Omicron
38. Characterization of an Escherichia coli-derived triple-type chimeric vaccine against human papillomavirus types 39, 68 and 70
39. Identification of a cross-neutralizing antibody that targets the receptor binding site of H1N1 and H5N1 influenza viruses
40. Whole blood GBP5 protein levels in patients with and without active tuberculosis
41. Development of a skin- and neuro-attenuated live vaccine for varicella
42. Structures of pseudorabies virus capsids
43. A potent synthetic nanobody with broad-spectrum activity neutralizes SARS-CoV-2 virus and the Omicron variant BA.1 through a unique binding mode
44. Female sex hormone, progesterone, ameliorates the severity of SARS-CoV-2-caused pneumonia in the Syrian hamster model
45. Pre-existing maternal IgG antibodies as a protective factor against congenital cytomegalovirus infection: A mother-child prospective cohort study
46. Glycoprotein E-Displaying Nanoparticles Induce Robust Neutralizing Antibodies and T-Cell Response against Varicella Zoster Virus.
47. WHO International Standards for antibodies to HPV6 HPV11 HPV31 HPV33 HPV45 HPV52 and HPV58.
48. Decisive reversal of lethal coronavirus disease 2019 in senescent hamster by synchronic antiviral and immunoregulatory intervention.
49. A stepwise docking molecular dynamics approach for simulating antibody recognition with substantial conformational changes
50. The Risk of Transfusion-Transmitted Hepatitis E Virus: Evidence from Seroprevalence Screening of Blood Donations
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.